Skip to main content

Table 1 Characteristics of the 253 patients with diffuse large B-cell lymphoma (DLBCL)

From: Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma

Variable

No. of patients [cases (%)]

Sex

 

 Men

137 (54.2)

 Women

116 (45.8)

Ann Arbor stage

 

 I

48 (19.0)

 II

78 (30.8)

 III

58 (22.9)

 IV

69 (27.3)

IPI score

 

 Low (0 or 1)

137 (54.1)

 Low/intermediate (2)

51 (20.2)

 High/intermediate (3)

44 (17.4)

 High (4 or 5)

21(8.3)

Chemotherapy

 

 R-EPOCH

25 (9.9)

 R-CHOP

228 (90.1)

  1. IPI, international prognostic index; R, rituximab; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisone; EPOCH, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin